Martine A Rothblatt United Therapeutics Corp (UTHR) insider trading activity

UTHR Quotes by TradingView

Martine A Rothblatt is Chairperson & CEO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $52,404. The most recent transaction as insider was on Dec 27, 2021, when has been sold 3,082 shares (Common Stock) at a price of $213.31 per share, resulting in proceeds of $657,421. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130
0% 3M change
0% 12M change
Total Value Held $52,404

MARTINE A ROTHBLATT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 27 2021
SELL
Open market or private sale
$657,421 $213.31 p/Share
3,082 Reduced 95.95%
130 Common Stock
Dec 27 2021
BUY
Exercise of conversion of derivative security
$164,640 $53.42 p/Share
3,082 Added 48.97%
3,212 Common Stock
Dec 22 2021
SELL
Open market or private sale
$623,920 $202.44 p/Share
3,082 Reduced 95.95%
130 Common Stock
Dec 22 2021
BUY
Exercise of conversion of derivative security
$164,640 $53.42 p/Share
3,082 Added 48.97%
3,212 Common Stock
Dec 20 2021
SELL
Open market or private sale
$616,400 $200.0 p/Share
3,082 Reduced 95.95%
130 Common Stock
Dec 20 2021
BUY
Exercise of conversion of derivative security
$164,640 $53.42 p/Share
3,082 Added 48.97%
3,212 Common Stock
Nov 24 2021
SELL
Open market or private sale
$618,573 $200.64 p/Share
3,083 Reduced 95.95%
130 Common Stock
Nov 24 2021
BUY
Exercise of conversion of derivative security
$164,694 $53.42 p/Share
3,083 Added 48.97%
3,213 Common Stock
Nov 22 2021
SELL
Open market or private sale
$617,895 $200.42 p/Share
3,083 Reduced 95.95%
130 Common Stock
Nov 22 2021
BUY
Exercise of conversion of derivative security
$164,694 $53.42 p/Share
3,083 Added 48.97%
3,213 Common Stock
Nov 17 2021
SELL
Open market or private sale
$622,458 $201.9 p/Share
3,083 Reduced 95.95%
130 Common Stock
Nov 17 2021
BUY
Exercise of conversion of derivative security
$164,694 $53.42 p/Share
3,083 Added 48.97%
3,213 Common Stock
Nov 15 2021
SELL
Open market or private sale
$627,236 $203.45 p/Share
3,083 Reduced 95.95%
130 Common Stock
Nov 15 2021
BUY
Exercise of conversion of derivative security
$164,694 $53.42 p/Share
3,083 Added 48.97%
3,213 Common Stock
Nov 10 2021
SELL
Open market or private sale
$616,600 $200.0 p/Share
3,083 Reduced 95.95%
130 Common Stock
Nov 10 2021
BUY
Exercise of conversion of derivative security
$164,694 $53.42 p/Share
3,083 Added 48.97%
3,213 Common Stock
Nov 08 2021
SELL
Open market or private sale
$619,498 $200.94 p/Share
3,083 Reduced 95.95%
130 Common Stock
Nov 08 2021
BUY
Exercise of conversion of derivative security
$164,694 $53.42 p/Share
3,083 Added 48.97%
3,213 Common Stock
Nov 04 2021
SELL
Open market or private sale
$616,600 $200.0 p/Share
3,083 Reduced 95.95%
130 Common Stock
Nov 04 2021
BUY
Exercise of conversion of derivative security
$164,694 $53.42 p/Share
3,083 Added 48.97%
3,213 Common Stock
Sep 17 2021
SELL
Bona fide gift
-
10 Reduced 7.14%
130 Common Stock
MAR

Martine A Rothblatt

Chairperson & CEO
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UTHR